Clinical trial Recruiting at 22 sites Observational Ages 37 Weeks to 18

Physiology-guided Epinephrine Dosing in Pediatric Cardiac Arrest

Official title: Physiology-directed Epinephrine Dosing in Pediatric Cardiac Arrest

Run by Children's Hospital of Philadelphia · NCT07890610 · Data updated 2026-11-12

This observational study looks at how a child’s body responds to epinephrine during in-hospital cardiac arrests to see if dosing can be guided by physiology.

Quick facts

Study typeObservational
Ages37 Weeks to 18 Years
SexAll
Enrollment1620 (estimated)
SponsorChildren's Hospital of Philadelphia
Academic / other
Locations22 sites (Orange, California and 21 other locations)
StatusRecruiting
StartedJuly 1, 2024
Main results expectedJune 30, 2029
Study endsJune 30, 2029
Registry record updatedOctober 22, 2026
Trial IDNCT07890610 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children in ICUs experiencing an arrest who receive at least one minute of chest compressions and do not meet exclusion criteria such as end-of-life CPR or pre-existing brain death at CPR start.

Probably not a fit

Patients with out-of-hospital arrest as the initial admission reason, ongoing VA-ECMO at CPR start, or whose care plan excludes aggressive CPR may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, multicenter cohort study will examine the physiologic responses to epinephrine during pediatric in-hospital cardiac arrest and explore dosing strategies based on initial responses. The team will use collected data to identify outcome-discriminating physiologic markers and to develop machine learning tools to guide intra-arrest therapy. Eligible participants are children in intensive care units who receive chest compressions for at least one minute, with several exclusions to avoid cases with poor prognosis or non-survivable conditions. The study is led by the Children’s Hospital of Philadelphia with NHLBI collaboration and includes sites in California, Colorado, and Utah. The aim is to improve decision-making for epinephrine administration during pediatric resuscitation.

Why it matters

Potential benefit: If successful, the study could inform personalized epinephrine dosing during pediatric cardiac arrest and support ML-guided intra-arrest therapy to improve outcomes.

How similar studies have gone: Prior work suggests physiological data can guide resuscitation decisions, but this specific physiology-directed dosing approach in pediatric IHCA is novel and exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Arrest in an ICU
* Patients received chest compressions for at least 1 minute

Exclusion Criteria:

* Lack of commitment to aggressive therapies (e.g., CPR performed as part of end-of-life care)
* Brain death determination prior to CPR
* Out-of-hospital cardiac arrest was the reason for initial admission to the hospital (known poor outcomes)
* Supported by Veno-Arterial Extra Corporeal Membrane Oxygenation at the start of CPR

Where it's running

  • Choc
    Orange, California, United States
    Recruiting
  • Stanford Medicine Children's Health
    Stanford, California, United States
    Recruiting
  • Children's Hospital Colorado
    Denver, Colorado, United States
    Recruiting
  • Nemours Children's Health
    Wilmington, Delaware, United States
    Recruiting
  • Children's Healthcare of Atlanta
    Atlanta, Georgia, United States
    Recruiting
  • Comer Children's Hospital
    Chicago, Illinois, United States
    Recruiting
Show 16 more locations
  • Riley Children's Health
    Indianapolis, Indiana, United States
    Recruiting
  • Stead Family Children's Hospital
    Iowa City, Iowa, United States
    Recruiting
  • Boston Children's Hospital
    Boston, Massachusetts, United States
    Recruiting
  • Washington University in St. Louis
    St Louis, Missouri, United States
    Recruiting
  • Cohen Children's Medical Center
    New Hyde Park, New York, United States
    Recruiting
  • Columbia University Irving Medical Center
    New York, New York, United States
    Recruiting
  • UNC Children's Hospital
    Chapel Hill, North Carolina, United States
    Recruiting
  • Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio, United States
    Recruiting
  • Nationwide Children's Hospital
    Columbus, Ohio, United States
    Recruiting
  • Children's Hospital of Philadelphia
    Philadelphia, Pennsylvania, United States
    Recruiting
  • Dell Children's Medical Center
    Austin, Texas, United States
    Recruiting
  • Medical City Children's Hospital
    Dallas, Texas, United States
    Recruiting
  • University of Texas Southwestern Medical Center
    Dallas, Texas, United States
    Recruiting
  • Children's Hospital of Richmond at VCU
    Richmond, Virginia, United States
    Recruiting
  • Seattle Children's
    Seattle, Washington, United States
    Recruiting
  • Children's Wisconsin
    Milwaukee, Wisconsin, United States
    Recruiting

Study contacts

  • Principal investigator: Ryan Morgan, MD, MTR — Children's Hospital of Philadelphia
  • Study coordinator: Jessica Goldstein
  • Email: goldsteij1@chop.edu
  • Phone: 215-590-1859

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.